Healthcare -
Biotechnology - NASDAQ - US
$ 0.84
-0.838 %
$ 65.7 M
Market Cap
5.25
P/E
CTMX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CTMX - CytomX Therapeutics, Inc.
30.2 M
LAST VALUE
-47.63%
2 YEAR CAGR
-26.36%
5 YEAR CAGR
27.34%
10 YEAR CAGR